Spin-off preparation

Preparing an immuno-peptidomics platform for spin-off by validating market potential and bringing in early adopter interest.

Enabling technologies

VITO Health and the Center for Proteomics at the University of Antwerp built strong expertise in mass spectrometry-based peptide analysis. Building on this expertise, Prof. Geert Baggerman and his team developed a state-of-the-art MS-based immuno-peptidomics platform to support biotech and biopharma companies in immunotherapy development.

I was asked to screen industry interest in this MS-based immuno-peptidomics service platform in the immunotherapy and adoptive cell therapy market. I interviewed relevant SMEs and large biotech companies across Europe to validate market appetite and early adopter interest.

I also estimated the business potential, developed pricing and potential business models, mapped the competitive landscape of service providers and the IP landscape, and calculated the financial needs to build a professional service platform.

The spin-off ImmuneSpec has since been founded.

Like what I did here? Let’s get in touch.

Call +32 476 85 38 76 or Send me an email

More background info? Read my resume.